Hacker News new | ask | show | jobs
by foxglacier 248 days ago
Don't be so quick to assume it was a failure not intentional. One of the comments in the article suggests it could have been to avoid PMPRB which is price control for patented drugs.
2 comments
PerryUlysses 247 days ago
The company said it was intentional, probably because of the reason you mentioned: “In a statement to Fortune, Novo Nordisk said there was no mistake regarding its patent maintenance fee in Canada.”
link
Scoundreller 247 days ago
I still don’t get that though: is that worth losing exclusivity over?

I guess they think some other production patent will let them maintain exclusivity without it being a patent on the drug itself?

link